openPR Logo
Press release

Award-winning speakers are meeting at the Global Pharma Manufacturing Summit 2013

01-29-2013 10:24 PM CET | Health & Medicine

Press release from: World Trade Group

Global Pharma Manufacturing Summit

Global Pharma Manufacturing Summit

Event dates and location:
8th Annual Global Pharma Manufacturing Summit 2013
June 27th-28th 2013
The Westin Copley Place, Boston, US
www.gpmsummit.com

Now in its eighth year, the Global Pharma Manufacturing Summit presents premier networking opportunities for pharma manufacturing industry leaders to discuss and share their expertise.

Over 150 senior executives and decision-makers will spend two days in June to discuss best practices about quality management, manufacturing excellence, outsourcing and contract manufacturing.

Manufacturers are facing increasing pressure to grow and evolve beyond strategies of the past. New technologies, heightened regulatory guidelines, and the oncoming wave of generic products are shaping a new exciting chapter for the industry.

The Global Pharma Manufacturing Summit has been produced with the help of an expert advisory board to ensure the program gets to the heart of the above issues currently facing the US pharma manufacturing industry.

At the event, the case studies, keynote sessions, workshops as well as panel discussions will be led by award-winning speakers; Christian Houborg, VP Service and Technical Operations, Lundbeck (Shingo Prize Silver Medallion Recipient 2012) and Darren Dasburg, VP Capacity Utilization, MedImmune (Winner of the 2011 Facility of the Year Award) to name a few.

What is new for 2013?

- The Global Pharma Manufacturing Summit is one of the only industry forums featuring manufacturing case studies about small and large molecule manufacturing
- The event explores manufacturing methods that improve operational efficiency, maintain compliance and reduce cost
- A first-hand update from the projects which are leading the next generation of pharma manufacturing in the US – featuring MedImmune, Novartis, Genentech, Merrimack Pharmaceuticals, Shire Pharmaceuticals and more
- Three dedicated streams addressing key topics in the manufacturing industry: manufacturing excellence, quality, outsourcing/contract manufacturing and managing CMO relationships

Additional details on the event including the full program, a list of speakers and registration information are available at www.gpmsummit.com

About World Trade Group:

World Trade Group (WTG) organize and run leading annual business events, bringing together senior executives from world class organisations for a unique blend of knowledge sharing, networking and deal making. For more information, please visit www.worldtradegroup.com

90 Union street
SE1 0NW
London, UK

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Award-winning speakers are meeting at the Global Pharma Manufacturing Summit 2013 here

News-ID: 250409 • Views:

More Releases from World Trade Group

WTG Launching Smart Grids Asia Summit in Singapore
WTG Launching Smart Grids Asia Summit in Singapore
Event dates and location: Smart Grids Asia Summit 25th-26th June 2013 Singapore www.smartgridsummitasia.com WTG’s best energy conference award-winner Smart Grids event is coming to Asia. Building on the success of recent smart grids summits in Europe, WTG is pleased to announce the launch of the Smart Grids Asia Summit on 25th-26th June 2013 in Singapore. According to the latest reports, the global smart grid market will be worth US$24.1 billion, with China, Japan and South Korea
Meet with over 120 senior early drug developers to discuss maximising drug inves …
The Early Drug Development Summit is taking place on 3rd-4th December 2012 at the Hotel Palace Berlin, Germany and attracts Europe's most senior early drug developers together to meet, network, and learn. Debate about smart deployment of drug development processes and platform technologies to help maximise new product value and increase the likelihood of new drugs being approved by regulators quickly. Participating in pre-arranged one-to-one meetings, benchmarking and sharing strategies on

More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the